Home » Topics » Regulatory

Regulatory
RSS

FDA approves Aptiom as monotherapy for partial-onset seizures

Aug. 31, 2015

Exelixis receives first regulatory approval of cobimetinib in Switzerland

Aug. 28, 2015

Tracleer approved in Japan for new digital ulcers in patients with systemic scleroderma

Aug. 26, 2015

Remicade approved in Japan for entero-Behcet's, neuro-Behcet's and vasculo-Behcet's disease

Aug. 25, 2015

Daiichi Sankyo announces Japanese approvals for supplementary indications

Aug. 25, 2015

FDA approves first treatment for hypoactive sexual desire disorder in women

Aug. 19, 2015

FDA approves Keveyis for primary hyperkalemic and hypokalemic periodic paralysis

Aug. 11, 2015

FDA approves Praluent to treat high LDL cholesterol

July 27, 2015

FDA approves Odomzo for locally advanced BCC

July 27, 2015

Evolocumab becomes first PCSK9 inhibitor approved in the world

July 22, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...